Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

The invention relates to a dengue virus tetravalent vaccine containing a common 30 nucleotide deletion (.DELTA.30) in the 3'-untranslated region of the genome of dengue virus serotypes 1, 2, 3, and 4, or antigenic chimeric dengue viruses of serotypes 1, 2, 3, and 4.

Web www.patentalert.com

< Fortified cereal bran to promote digestive health

> Non-systemic control of parasites

> Dosage forms contained within a capsule or sachet

~ 00512